Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

STX 140

Known as: STX-140, STX140 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Despite paclitxael's clinical success, treating hormone-refractory breast cancer remains challenging. Paclitaxel has a poor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Background:Class III β-tubulin overexpression is a marker of resistance to microtubule disruptors in vitro, in vivo and in the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2009
2009
The anti-proliferative and anti-angiogenic properties of the endogenous oestrogen metabolite, 2-methoxyoestradiol (2-MeOE2), are… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2009
2009
Many anticancer drugs target microtubules and induce apoptosis. However, improved microtubule-targeting drugs, such as STX140 and… Expand
Is this relevant?
2008
2008
Drug combination therapy is a key strategy to improve treatment efficacy and survival of cancer patients. In this study the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Purpose:The aimof these studieswas to characterize the actionof STX140 in a P-glycoprotein ^ overexpressing tumor cell line both… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
UNLABELLED There is a continued need for orally bioavailable anticancer compounds that exhibit good efficacy against breast… Expand
Is this relevant?
2008
2008
UNLABELLED This study characterises two recently developed anticancer agents in vitro and in vivo, 2-methoxyoestra-1,3,5(10), 16… Expand
Is this relevant?
2008
2008
PURPOSE The aim of these studies was to characterize the action of STX140 in a P-glycoprotein-overexpressing tumor cell line both… Expand
Is this relevant?
2007
2007
Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?